Recombinant multi-species ATP6V1B1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ATP6V1B1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a component of vacuolar ATPase (V-ATPase), a multisubunit enzyme that mediates acidification of eukaryotic intracellular organelles. V-ATPase dependent organelle acidification is necessary for such intracellular processes as protein sorting, zymogen activation, receptor-mediated endocytosis, and synaptic vesicle proton gradient generation. V-ATPase is composed of a cytosolic V1 domain and a transmembrane V0 domain. The V1 domain consists of three A and three B subunits, two G subunits plus the C, D, E, F, and H subunits. The V1 domain contains the ATP catalytic site. The V0 domain consists of five different subunits: a, c, c', c'', and d. Additional isoforms of many of the V1 and V0 subunit proteins are encoded by multiple genes or alternatively spliced transcript variants. This encoded protein is one of two V1 domain B subunit isoforms and is found in the kidney. Mutations in this gene cause distal renal tubular acidosis associated with sensorineural deafness. [provided by RefSeq, Jul 2008]
The Alternative Names of target: ATP6B1,ATP6V1B1,Atp6b1,Atp6v1b1,D630003L15,D630030L16Rik,D630039P21Rik,DRTA2,Endomembrane proton pump 58 kDa subunit,RTA1B,V-ATPase subunit B 1,V-type proton ATPase subunit B,VATB,VMA2,VPP3,Vacuolar proton pump subunit B 1,Vpp-3,Vpp3,kidney isoform
Go
to ATP6V1B1 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-IP9589-Ag-1/ GM-Tg-hg-IP9589-Ag-2 | Human ATP6V1B1 protein | Human |
GM-Tg-rg-IP9589-Ag-1/ GM-Tg-rg-IP9589-Ag-2 | Rat ATP6V1B1 protein | Rat |
GM-Tg-mg-IP9589-Ag-1/ GM-Tg-mg-IP9589-Ag-2 | Mouse ATP6V1B1 protein | Mouse |
GM-Tg-cynog-IP9589-Ag-1/ GM-Tg-cynog-IP9589-Ag-2 | Cynomolgus/Rhesus macaque ATP6V1B1 protein | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-IP9589-Ag-1/ GM-Tg-felg-IP9589-Ag-2 | Feline ATP6V1B1 protein | Feline |
GM-Tg-cang-IP9589-Ag-1/ GM-Tg-cang-IP9589-Ag-2 | Canine ATP6V1B1 protein | Canine |
GM-Tg-bovg-IP9589-Ag-1/ GM-Tg-bovg-IP9589-Ag-2 | Bovine ATP6V1B1 protein | Bovine |
GM-Tg-equg-IP9589-Ag-1/ GM-Tg-equg-IP9589-Ag-2 | Equine ATP6V1B1 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. |
GM-Tg-hg-IP9589-Ag-1/ GM-Tg-hg-IP9589-Ag-2;
GM-Tg-rg-IP9589-Ag-1/ GM-Tg-rg-IP9589-Ag-2;
GM-Tg-mg-IP9589-Ag-1/ GM-Tg-mg-IP9589-Ag-2; GM-Tg-cynog-IP9589-Ag-1/ GM-Tg-cynog-IP9589-Ag-2; GM-Tg-felg-IP9589-Ag-1/ GM-Tg-felg-IP9589-Ag-2; GM-Tg-cang-IP9589-Ag-1/ GM-Tg-cang-IP9589-Ag-2; GM-Tg-bovg-IP9589-Ag-1/ GM-Tg-bovg-IP9589-Ag-2; GM-Tg-equg-IP9589-Ag-1/ GM-Tg-equg-IP9589-Ag-2 |
Products Name | ATP6V1B1 protein |
Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
Target Name | ATP6V1B1 |
Protein Sub-location | Introcelluar Protein |
Isotypes | Recombinant protein |
Expression platform | Mammalian cell |
Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
Tag | His |
Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ATP6V1B1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab
GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.